CAR-T Immunotherapy Targeting CD19- ALL

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CAR-T Immunotherapy Targeting CD19- ALL	Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm	Not yet recruiting	Phase 1 / Phase 2	2026-08-26		NCT04016129

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shenzhen Geno-Immune Medical Institute	43

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Shenzhen Geno-Immune Medical Institute	Shenzhen	China	39

Clinical trials